Want to join the conversation?
$LH's revenue from LabCorp Diagnostics for 2015 rose by 6.2% from last year. This increase was driven by organic volume growth, measured by requisitions of 3.2%. Beacon LBS, its technology-enabled solution providing point-of-care decision support, contributed 0.9%. The increase in revenues was unfavorably impacted by currency.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?